Ultra-low-dose aspirin may reduce bleeding in portal hypertension patientsNovember 14th, 2007 - 1:58 am ICT by admin
Further, this effect is mediated by Cyclooxygenase 2 inhibition.
Ultra-low-dose aspirin has a prothrombotic effect that is the opposite of that observed with usual doses for the prevention of stroke or heart attack. The antithrombotic properties of low-dose aspirin are achieved by the inhibition of COX 1 in platelets.
Aspirin is the most widely used antithrombotic agent. Prior studies in rats have shown that the prothrombotic properties of ultra-low-dose aspirin are not mediated by platelets but by endothelial cells, and as such they have the potential of reversing the platelet-endothelial cell interaction alterations observed in portal hypertension.
According to researchers, till date no clear explanation has existed to explain the effect of such a small dose of aspirin, and no mechanism has been found to explain this contradictory action.
The prothrombotic effects of COX 2 inhibitors became evident in 2004 when one of the most widely accepted non-steroidal anti-inflammatory drugs was withdrawn from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use. Only aspirin has been demonstrated to have a prothrombotic effect at a very low dose.
Portal hypertension is a major complication of chronic liver disease, and bleeding is one of its most severe problems, leading often to death. Currently no treatment is used to modify the altered platelet activity observed in this pathology.
The new research, is published in the October 14 issue of the World Journal of Gastroenterology. (ANI)
- Iranian scientist creates gas-filled aspirin to fight cancer - Mar 13, 2012
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Aspirin safer than warfarin in preventing stroke: Study - May 03, 2012
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- Taking aspirin for heart disease prevention is less costly, more effective - Feb 23, 2011
- Taking aspirin daily 'cuts prostate cancer risk by 30pc' - Aug 12, 2010
- An aspirin a day 'cuts cancer death rate by 50pc' - Dec 07, 2010
- Culprits in life-threatening clotting disorder uncovered - Dec 04, 2010
- High and low dose aspirin can protect heart - Mar 27, 2012
- Exposure to chemical fosters anxiety - Sep 09, 2012
- Coffee, aspirin best antidote to hangover - Jan 18, 2011
- Top 10 major advances in heart disease in 2010 - Dec 22, 2010
- Aspirin use linked to brain microbleeds in elderly - Apr 14, 2009
- Study: Aspirin cuts cancer risk by 20% - Dec 08, 2010
- Advance made to counter cell damage caused by excess radiation - Jun 24, 2010
Tags: anti inflammatory drugs, antithrombotic, cell alterations, cell interaction, chronic liver disease, cox 2 inhibitors, endothelial cell, endothelial cells, heart attack, hypertension patients, inhibition, low dose aspirin, most widely accepted, most widely used, platelet, platelets, portal hypertension, prevention of stroke, widely, world journal of gastroenterology